Login / Signup

Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy.

Zui LiuWei OuNing LiSi-Yu Wang
Published in: Thoracic cancer (2018)
Apatinib appears to be effective and safe for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy.
Keyphrases
  • advanced non small cell lung cancer
  • epidermal growth factor receptor
  • locally advanced
  • open label
  • combination therapy
  • chemotherapy induced
  • clinical trial
  • rectal cancer
  • radiation therapy